文献速递银屑病与炎症性皮肤病

在银屑病中启动基于价值的医疗:为日常临床实践提出一套基于价值的结局集

Initiating value-based healthcare in psoriasis: Proposing a value-based outcome set for daily clinical practice.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2022-11-16

该研究采用混合方法(系统综述、改良名义群体技术、患者排序、文献回顾和试点可行性测试)开发了一套用于日常实践的基于价值的结局集(VOS)。在120例患者中,症状控制、治疗疗效、对医疗的信心和疾病控制被评分为最重要,共选择12种由患者和提供者报告的测量工具。该VOS是首个以基于价值的方式评估银屑病照护的提案。

要点

  • 患者排序最重要的结局为症状控制、治疗疗效、对医疗的信心和疾病控制。
  • 最不重要的结局为合并症控制、生产力和照护成本。
  • 共选择12种由患者和提供者报告的测量工具,患者部分中位完成时间为30分钟(IQR 2.8)。

核心结论

  • 该VOS是首个以基于价值的方式评估银屑病照护的提案,测量这些结局可在现有资源现实内批判性评价和改进当前照护流程,从而增加患者价值。

研究设计与样本

  • 采用混合方法,包括四个阶段:系统综述提供23个患者相关结局的概览;改良名义群体技术(NGT)由患者评估这些结局是否代表其所有相关结局;患者对结局的重要性排序;文献回顾评估可用且合适的测量工具;最后在患者中进行试点可行性测试。

主要发现

  • 在NGT后,23个结局中的两个从排序练习中省略;排序练习有120例患者参与,中位年龄50.0岁(IQR 25.0),36.7%为女性,中位PASI评分2.4(IQR 5.2),治疗从外用药物到生物制剂不等。
  • 评分为最重要的结局是症状控制、治疗疗效、对医疗的信心和疾病控制;最不重要的结局是合并症控制、生产力和照护成本。
  • 结局的排序间显示显著差异(p < 0.001)。
  • 共选择12种由患者和提供者报告的测量工具来测量该VOS中的结局;患者部分的中位完成时间为30分钟(IQR 2.8)。

关键数值与推荐

  • 患者排序中最重要的结局:症状控制、治疗疗效、对医疗的信心和疾病控制;最不重要的结局:合并症控制、生产力和照护成本;排序差异p < 0.001。
  • 共选择12种由患者和提供者报告的测量工具;患者部分中位完成时间30分钟(IQR 2.8)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With the current trend in healthcare moving towards a more value-based approach, it is essential to understand what value encompasses. OBJECTIVES: To develop an actionable value-based outcome set (VOS) for daily practice. METHODS: A mixed method approach was used consisting of four phases. Formerly, a systematic review was conducted, providing an overview of all patient-relevant outcomes defined in current literature. These 23 outcomes were then presented to a group of patients, using a modified nominal group technique (NGT), to establish whether these results represented all of their relevant outcomes. Subsequently, these outcomes were ranked according to importance by patients attending our academic specialized psoriasis clinic. A review of the literature was performed to assess which instruments were available and suitable to evaluate the outcomes in this VOS. Finally, a pilot feasibility test was performed amongst patients. RESULTS: Of the 23 outcomes, two were omitted from the ranking exercise after the NGT. In the ranking exercise, 120 patients participated. The median age was 50.0 (IQR 25.0) years and 36.7% were female. Median PASI score was 2.4 (IQR 5.2), and treatments varied from topicals to biologicals. The outcomes scored as most important were symptom control, treatment efficacy, confidence in care and control of disease. The least important outcomes were comorbidity control, productivity and cost of care. A significant difference was shown between the ranking of the outcomes (p < 0.001). In total, 12 instruments were selected, which are reported by both patient and provider, to measure the outcomes in this VOS. Median completion time for the patient part was 30 min (IQR 2.8). CONCLUSIONS: This VOS is a first proposal to evaluate psoriasis care in a value-based manner. Measuring these outcomes can enable us to critically appraise and improve current care processes, within the reality of available resources, thereby increasing value for patients.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Hilhorst NT, Deprez E, Balak DMW, et al. Initiating value-based healthcare in psoriasis: Proposing a value-based outcome set for daily clinical practice. J Eur Acad Dermatol Venereol. 2022. PMID: 36310349. doi:10.1111/jdv.18696

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。